Katie Farley, director, product management at MasterControl, explores five pharmaceutical trends, what’s driving them, and how adopting them can lead to eliminating manufacturing errors, enhancing performance, and gaining a competitive advantage.
Mark Hilhorst, CEO of Jekson Vision, provides insight into the stringent quality checks needed that are crucial to improve patient safety in the pharma market, and how automation solutions can help with this, while meeting growing market demand.
Kari Miller, sr. director, Product Management, SmartSolve, IQVIA explores why purpose-built QMS technology is necessary for the life science industry, from mitigating risk to maintaining regulatory compliance.
Marco Pelka, market manager PCE of Mettler-Toledo, explains how manufacturers and packaging companies in this field can harness product inspection to ensure they produce high quality liquid pharmaceutical products.
Anne-Cecile Bayne, global science & innovation lead Pharma & Medical Nutrition, DSM discusses the benefits of using antioxidants to block nitrosamine development in drug products, and futureproof pharma formulations.
Here Ian Loudon, international sales and marketing manager at remote monitoring instrumentation manufacturer Omniflex, discusses how temperature monitoring systems can be cost effective, reliable and compliant with regulatory standards.
Natasha Rivas, vice president of quality and regulatory, and Jose Cruz, director of vector manufacturing at Genezen, explore the difficulties in ensuring cGMP compliance is achieved throughout viral vector production.
Calvin Kim, senior director and head of IT Quality Systems & Validation at Samsung Biologics explores the fundamentals of data integrity and why a lack of critical strategic thinking could be affecting the success of implementing the technology.
Dr Amit Katiyar director, Pharma Services Group within Thermo Fisher Scientific on how a new method streamlines the development and quality control of biotherapeutics.
Dr Toby Astill, global market manager - Cannabis and Hemp Markets at PerkinElmer, talks about the growth of cannabis in the pharmaceutical industry and the importance of chromatography to this sector.
Mark W. Womack, CEO of Stelis Biopharma, shares his views on the speed and compliance balancing act to achieve quality during a contract manufacturing operation.
